Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Low Beta Income ETF FT (FTLB)

Low Beta Income ETF FT (FTLB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
20.90 +0.02 (+0.10%) 05/10/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 20.90 unch (unch) -
Quote Overview for Tue, May 10th, 2022
Day Low
20.64
Day High
20.98
Open 20.86
Previous Close 20.88 20.88
Volume 4,600 4,600
Avg Vol 4,490 4,490
Stochastic %K 16.99% 16.99%
Weighted Alpha -4.70 -4.70
5-Day Change -0.94 (-4.29%) -0.94 (-4.29%)
52-Week Range 20.34 - 22.98 20.34 - 22.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family N/A
  • Assets Under Management 0
  • Shares Outstanding, K 650
  • 60-Month Beta 0.43
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.66 (3.16%)
  • Most Recent Dividend N/A on N/A
  • Management Fee N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.64 +1.28%
on 05/10/22
Period Open: 22.63
22.98 -9.03%
on 04/20/22
-1.73 (-7.65%)
since 04/08/22
3-Month
20.64 +1.28%
on 05/10/22
Period Open: 21.99
22.98 -9.03%
on 04/20/22
-1.09 (-4.93%)
since 02/10/22
52-Week
20.34 +2.77%
on 06/09/21
Period Open: 21.53
22.98 -9.03%
on 04/20/22
-0.63 (-2.91%)
since 05/10/21

Most Recent Stories

More News
First Trust Announces Changes in Investment Strategies and Other Related Matters for First Trust Hedged BuyWrite Income ETF

First Trust Advisors L.P. (“FTA”) announced today that First Trust Hedged BuyWrite Income ETF (Nasdaq: FTLB) (the “Fund”), a series of First Trust Exchange-Traded Fund VI (the “Trust”), will...

FTLB : 20.90 (+0.13%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
HISF : 43.55 (-0.36%)
FMB : 49.21 (-0.22%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FNK : 46.47 (+2.81%)
FEUZ : 47.83 (+2.68%)
FEMS : 36.49 (+2.56%)
FTSL : 45.18 (-0.53%)
LEGR : 46.99 (+2.08%)
FCAL : 47.49 (-0.65%)
ISHP : 34.89 (+2.80%)
FNX : 101.49 (+2.70%)
RNLC : 36.80 (+1.28%)
FPXE : 26.30 (+2.95%)
NFTY : 57.80 (+0.77%)
NXTG : 82.88 (+1.76%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FDIV : 25.07 (+1.87%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
FMB : 49.21 (-0.22%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FDIV : 25.07 (+1.87%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
FMB : 49.21 (-0.22%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FNK : 46.47 (+2.81%)
FEUZ : 47.83 (+2.68%)
FEMS : 36.49 (+2.56%)
FTSL : 45.18 (-0.53%)
LEGR : 46.99 (+2.08%)
FCAL : 47.49 (-0.65%)
FTSM : 59.93 (-0.01%)
FTGC : 24.51 (+0.53%)
FAAR : 26.67 (+0.72%)
FJP : 55.30 (+3.52%)
FNX : 101.49 (+2.70%)
RNLC : 36.80 (+1.28%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FDIV : 25.07 (+1.87%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
FMB : 49.21 (-0.22%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FDIV : 25.07 (+1.87%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
FMB : 49.21 (-0.22%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FNK : 46.47 (+2.81%)
FEUZ : 47.83 (+2.68%)
FEMS : 36.49 (+2.56%)
FTSL : 45.18 (-0.53%)
LEGR : 46.99 (+2.08%)
FCAL : 47.49 (-0.65%)
FNX : 101.49 (+2.70%)
RNLC : 36.80 (+1.28%)
NFTY : 57.80 (+0.77%)
NXTG : 82.88 (+1.76%)
FPXI : 48.23 (+2.86%)
FCVT : 33.84 (+1.65%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

MDIV : 15.62 (+0.58%)
FTLB : 20.90 (+0.13%)
FTSL : 45.18 (-0.53%)
FCAL : 47.49 (-0.65%)
FMHI : 45.98 (-0.35%)
LDSF : 18.72 (-0.27%)
FDIV : 25.07 (+1.87%)
FTHI : 20.84 (+1.46%)
FIXD : 43.03 (-0.14%)
LMBS : 48.72 (-0.20%)
FEMB : 27.05 (+0.15%)
FMB : 49.21 (-0.22%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
MRK : 78.97 (+1.44%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
RY : 117.97 (+2.40%)
MRK : 78.97 (+1.44%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
RY.TO : 163.03 (+2.29%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

COP : 89.76 (+2.52%)
F : 9.65 (+1.90%)
JNJ : 157.75 (+0.53%)
SLB : 34.61 (-0.03%)
IMGN : 31.23 (unch)
CSX : 27.78 (+1.17%)
MRO : 28.55 (-1.28%)
TSCO : 50.28 (+1.39%)
NQM25 : 18,688.25 (+1.65%)
ESM25 : 5,393.25 (+1.48%)
FANG : 136.54 (+3.17%)
SG : 17.17 (+1.24%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 39.45 (-1.37%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

BCT.TO : 7.12 (+20.27%)
PBYI : 3.01 (+5.24%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
BCTX : 5.35 (+27.68%)
GILD : 105.51 (+1.13%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

C : 64.55 (+2.97%)
AZN : 67.87 (+1.45%)
IMGN : 31.23 (unch)
LEA : 80.85 (+2.91%)
GILD : 105.51 (+1.13%)
SGEN : 228.74 (-0.07%)
PFE : 22.53 (+2.22%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
TXN : 146.76 (+0.79%)
ABNB : 114.91 (+2.96%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
TSLA : 237.97 (+4.60%)
KNX : 39.03 (+1.06%)
GFS : 31.71 (+1.12%)
QCOM : 138.74 (+1.91%)
LRCX : 63.48 (+1.75%)
$DOWI : 39,186.98 (+2.66%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
GCM25 : 3,361.7 (-1.69%)
CVX : 137.30 (+2.67%)
SLB : 34.61 (-0.03%)
MRO : 28.55 (-1.28%)
ABNB : 114.91 (+2.96%)
TXN : 146.76 (+0.79%)
^USDJPY : 142.359 (+0.54%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
OXY : 39.97 (+2.43%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
MRK : 78.97 (+1.44%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
RY : 117.97 (+2.40%)
MRK : 78.97 (+1.44%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
RY.TO : 163.03 (+2.29%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

COP : 89.76 (+2.52%)
F : 9.65 (+1.90%)
JNJ : 157.75 (+0.53%)
SLB : 34.61 (-0.03%)
IMGN : 31.23 (unch)
CSX : 27.78 (+1.17%)
MRO : 28.55 (-1.28%)
TSCO : 50.28 (+1.39%)
NQM25 : 18,688.25 (+1.65%)
ESM25 : 5,393.25 (+1.48%)
FANG : 136.54 (+3.17%)
SG : 17.17 (+1.24%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 39.45 (-1.37%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

BCT.TO : 7.12 (+20.27%)
PBYI : 3.01 (+5.24%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
BCTX : 5.35 (+27.68%)
GILD : 105.51 (+1.13%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

C : 64.55 (+2.97%)
AZN : 67.87 (+1.45%)
IMGN : 31.23 (unch)
LEA : 80.85 (+2.91%)
GILD : 105.51 (+1.13%)
SGEN : 228.74 (-0.07%)
PFE : 22.53 (+2.22%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
TXN : 146.76 (+0.79%)
ABNB : 114.91 (+2.96%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
TSLA : 237.97 (+4.60%)
KNX : 39.03 (+1.06%)
GFS : 31.71 (+1.12%)
QCOM : 138.74 (+1.91%)
LRCX : 63.48 (+1.75%)
$DOWI : 39,186.98 (+2.66%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
GCM25 : 3,361.7 (-1.69%)
CVX : 137.30 (+2.67%)
SLB : 34.61 (-0.03%)
MRO : 28.55 (-1.28%)
ABNB : 114.91 (+2.96%)
TXN : 146.76 (+0.79%)
^USDJPY : 142.359 (+0.54%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
OXY : 39.97 (+2.43%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
MRK : 78.97 (+1.44%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

ONCY : 0.6000 (+4.35%)
AZN : 67.87 (+1.45%)
RY : 117.97 (+2.40%)
MRK : 78.97 (+1.44%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
ONC.TO : 0.84 (+6.33%)
RY.TO : 163.03 (+2.29%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

COP : 89.76 (+2.52%)
F : 9.65 (+1.90%)
JNJ : 157.75 (+0.53%)
SLB : 34.61 (-0.03%)
IMGN : 31.23 (unch)
CSX : 27.78 (+1.17%)
MRO : 28.55 (-1.28%)
TSCO : 50.28 (+1.39%)
NQM25 : 18,688.25 (+1.65%)
ESM25 : 5,393.25 (+1.48%)
FANG : 136.54 (+3.17%)
SG : 17.17 (+1.24%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 39.45 (-1.37%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

BCT.TO : 7.12 (+20.27%)
PBYI : 3.01 (+5.24%)
LLY : 827.54 (+1.16%)
IMGN : 31.23 (unch)
BCTX : 5.35 (+27.68%)
GILD : 105.51 (+1.13%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

C : 64.55 (+2.97%)
AZN : 67.87 (+1.45%)
IMGN : 31.23 (unch)
LEA : 80.85 (+2.91%)
GILD : 105.51 (+1.13%)
SGEN : 228.74 (-0.07%)
PFE : 22.53 (+2.22%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
TXN : 146.76 (+0.79%)
ABNB : 114.91 (+2.96%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
TSLA : 237.97 (+4.60%)
KNX : 39.03 (+1.06%)
GFS : 31.71 (+1.12%)
QCOM : 138.74 (+1.91%)
LRCX : 63.48 (+1.75%)
$DOWI : 39,186.98 (+2.66%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

AVGO : 169.58 (+2.03%)
DG : 96.79 (+1.23%)
GCM25 : 3,361.7 (-1.69%)
CVX : 137.30 (+2.67%)
SLB : 34.61 (-0.03%)
MRO : 28.55 (-1.28%)
ABNB : 114.91 (+2.96%)
TXN : 146.76 (+0.79%)
^USDJPY : 142.359 (+0.54%)
$IUXX : 18,276.41 (+2.63%)
ZNM25 : 110-275 (+0.06%)
OXY : 39.97 (+2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 21.38
2nd Resistance Point 21.18
1st Resistance Point 21.04
Last Price 20.90
1st Support Level 20.70
2nd Support Level 20.50
3rd Support Level 20.36

See More

52-Week High 22.98
Fibonacci 61.8% 21.97
Fibonacci 50% 21.66
Fibonacci 38.2% 21.35
Last Price 20.90
52-Week Low 20.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.